AFJK
Aimei Health Technology Co., Ltd.
Key Financials
Net Income
$1.1M
↓ 58.5%
Operating Income
$-835759
↑ 21.5%
EPS (Diluted)
$0.08
N/A
Shareholders' Equity
$-4058731.00
↓ 174.9%
Total Assets
$12.1M
↓ 83.6%
Total Liabilities
$4.1M
↑ 169.5%
Operating Cash Flow
$-565100.00
↑ 15.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/13/2026 | View on SEC |
| SCHEDULE 13G/A | 8/10/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| SCHEDULE 13G/A | 8/5/2026 | View on SEC |
| 8-K | 7/8/2026 | View on SEC |
| 8-K | 7/6/2026 | View on SEC |
| 3 | 7/1/2026 | View on SEC |
| 8-K | 6/29/2026 | View on SEC |
| 10-Q | 6/16/2026 | View on SEC |
| 8-K | 6/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AFJK |
| Company Name | Aimei Health Technology Co., Ltd. |
| CIK | 1979005 |
| Sector | Blank Checks |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 6770 |
| SIC Description | Blank Checks |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 34 678 035200 |